問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-03-06 - 2022-02-28
Condition/Disease
NSCLC
Test Drug
Telisotuzumab Vedotin (ABBV-399)
Participate Sites11Sites
Recruiting11Sites
2022-09-01 - 2025-12-31
Advanced Solid Tumors
ABBV-400
Not yet recruiting3Sites
Recruiting8Sites
2023-12-01 - 2026-07-11
Participate Sites4Sites
Recruiting4Sites
2025-01-01 - 2029-12-12
Participate Sites12Sites
Recruiting12Sites
2019-01-01 - 2030-12-31
Participate Sites13Sites
Recruiting13Sites
2021-03-17 - 2035-12-31
Participate Sites5Sites
Recruiting5Sites
2013-08-12 - 2026-03-17
2025-11-19 - 2030-06-30
Participate Sites10Sites
Recruiting10Sites
2023-01-01 - 2025-10-31
Participate Sites7Sites
Recruiting7Sites
2023-05-01 - 2028-12-31
Participate Sites2Sites
Recruiting2Sites
全部
